Monitoring Crohn’s disease during anti-TNF-α therapy: validation of the magnetic resonance enterogra...
Monitoring Crohn’s disease during anti-TNF-α therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Objectives
To assess the ability of magnetic resonance enterography global score (MEGS) to characterise Crohn’s disease (CD) response to anti-TNF-α therapy.
Methods
Thirty-six CD patients (median age 26 years, 20 males) commencing anti-TNF-α therapy with concomitant baseline MRI enterography (MRE) were identified retrospectively. Patients’...
Alternative Titles
Full title
Monitoring Crohn’s disease during anti-TNF-α therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1808627173
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808627173
Other Identifiers
ISSN
0938-7994
E-ISSN
1432-1084
DOI
10.1007/s00330-015-4036-1
